Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Haloperidol decanoate 100mg/1ml inj ampoules
0402020T0AAABAB
|
Haloperidol decanoate | Haloperidol decanoate | Central Nervous System | 1,208 |
|
Haloperidol decanoate 50mg/1ml inj ampoules
0402020T0AAAAAA
|
Haloperidol decanoate | Haloperidol decanoate | Central Nervous System | 841 |
|
Haldol Decanoate 100mg/1ml solution for injection ampoules
0402020T0BBABAB
|
Haldol Decan | Haloperidol decanoate | Central Nervous System | 285 |
|
Haldol Decanoate 50mg/1ml solution for injection ampoules
0402020T0BBAAAA
|
Haldol Decan | Haloperidol decanoate | Central Nervous System | 177 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.